Literature DB >> 1499552

The structure of pneumococcal lipoteichoic acid. Improved preparation, chemical and mass spectrometric studies.

T Behr1, W Fischer, J Peter-Katalinić, H Egge.   

Abstract

Pneumococcal lipoteichoic acid was extracted and purified by a novel, quick and effective procedure. Structural analysis included methylation, periodate oxidation, Smith degradation, oxidation with CrO3, and fast-atom-bombardment mass spectrometry. Hydrolysis with 48% (by mass) HF and subsequent phase partition yielded the lipid anchor (I), the dephosphorylated repeating unit of the chain (II) and a cleavage product of the latter (III). The proposed structures are: (I) Glc(beta 1----3)AATGal(beta 1----3)Glc(alpha 1----3)acyl2Gro, (II) Glc(beta 1----3)AATGal(alpha 1----4)GalNAc(alpha 1----3)GalNAc(beta 1----1)ribitol and (III) Glc(beta 1----3)AATGal(alpha 1----4)GalNAc(alpha 1----3)GalNAc, where AATGal is 2-acetamido-4-amino-2,4,6-trideoxygalactose, and all sugars are in the pyranose form and belong to the D-series. Alkaline phosphodiester cleavage of lipoteichoic acid, followed by treatment with phosphomonoesterase, resulted in the formation of II and IV, with IV as the prevailing species: [sequence: see text] The linkage between the repeating units was established as phosphodiester bond between ribitol 5-phosphate and position 6 of the glucosyl residue of adjacent units. The chain was shown to be linked to the lipid anchor by a phosphodiester between its ribitol 5-phosphate terminus and position 6 of the non-reducing glucosyl terminus of I. The lipoteichoic acid is polydisperse: the chain length may vary between 2 and 8 repeating units and variations were also observed for the fatty acid composition of the diacylglycerol moiety. Preliminary results suggest that repeating units II and IV are enriched in separate molecular species. All species were associated with Forssman antigenicity, albeit to a various extent when related to the non-phosphocholine phosphorus. Owing to its unique structure, the described macroamphiphile may be classified as atypical lipoteichoic acid.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1499552     DOI: 10.1111/j.1432-1033.1992.tb17143.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  36 in total

Review 1.  Properties and biological role of streptococcal fratricins.

Authors:  Kari Helene Berg; Truls Johan Biørnstad; Ola Johnsborg; Leiv Sigve Håvarstein
Journal:  Appl Environ Microbiol       Date:  2012-03-09       Impact factor: 4.792

2.  Generation and properties of a Streptococcus pneumoniae mutant which does not require choline or analogs for growth.

Authors:  J Yother; K Leopold; J White; W Fischer
Journal:  J Bacteriol       Date:  1998-04       Impact factor: 3.490

3.  D-Alanylcardiolipin, a major component of the unique lipid pattern of Vagococcus fluvialis.

Authors:  W Fischer; D Arneth-Seifert
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

4.  Polysaccharide biosynthesis locus required for virulence of Bacteroides fragilis.

Authors:  M J Coyne; A O Tzianabos; B C Mallory; V J Carey; D L Kasper; L E Comstock
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

5.  A myeloid hypoxia-inducible factor 1α-Krüppel-like factor 2 pathway regulates gram-positive endotoxin-mediated sepsis.

Authors:  Ganapati H Mahabeleshwar; Muhammad Awais Qureshi; Yoichi Takami; Nikunj Sharma; Jerry B Lingrel; Mukesh K Jain
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

6.  Predicted functions and linkage specificities of the products of the Streptococcus pneumoniae capsular biosynthetic loci.

Authors:  David M Aanensen; Angeliki Mavroidi; Stephen D Bentley; Peter R Reeves; Brian G Spratt
Journal:  J Bacteriol       Date:  2007-08-31       Impact factor: 3.490

7.  Moxifloxacin in the therapy of experimental pneumococcal meningitis.

Authors:  H Schmidt; A Dalhoff; K Stuertz; F Trostdorf; V Chen; O Schneider; C Kohlsdorfer; W Brück; R Nau
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

8.  Characterization of lipoteichoic acids as Lactobacillus delbrueckii phage receptor components.

Authors:  Liisa Räisänen; Karin Schubert; Tiina Jaakonsaari; Tapani Alatossava
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

9.  Evidence of immunostimulating lipoprotein existing in the natural lipoteichoic acid fraction.

Authors:  Masahito Hashimoto; Maiko Furuyashiki; Ryoko Kaseya; Yuka Fukada; Mai Akimaru; Kazue Aoyama; Toshiomi Okuno; Toshihide Tamura; Teruo Kirikae; Fumiko Kirikae; Nobutaka Eiraku; Hirofumi Morioka; Yukari Fujimoto; Koichi Fukase; Katsuhiro Takashige; Yoichiro Moriya; Shoichi Kusumoto; Yasuo Suda
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

10.  Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2.

Authors:  Seung Hyun Han; Je Hak Kim; Michael Martin; Suzanne M Michalek; Moon H Nahm
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.